Internal Medicine, Nephrology · Visalia, CA
NPI
1548346695
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
503 S. Watson St.
Visalia, CA, 93277
Phone (559) 623-9636
Groups this clinician bills Medicare through
Medicare paid, 2024
$975K
9,722 services
Medicare patients, 2024
1,185
Average age 74
Drug cost, 2024
$1.6M
5,682 prescriptions
Company payments, 2025
$3,478
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tom Yang was code 99232 (hospital e&m - subsequent), 1,301 times for 185 patients. In total Tom Yang billed 9,722 services in 30 codes, and Medicare paid $975K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,301 | 185 | $66.53 | $87K |
| 99213 Office E&M - Established | Office | 1,277 | 745 | $78.21 | $100K |
| 99214 Office E&M - Established | Office | 1,274 | 670 | $105.92 | $135K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,246 | 717 | $13.91 | $17K |
| 90960 ESRD Related Services (not dialysis) | Office | 1,078 | 145 | $300.41 | $324K |
| 99457 E&M - Miscellaneous | Office | 624 | 104 | $41.42 | $26K |
| 99233 Hospital E&M - Subsequent | Facility | 547 | 149 | $100.11 | $55K |
| 99454 E&M - Miscellaneous | Office | 420 | 83 | $41.20 | $17K |
| 99458 E&M - Miscellaneous | Office | 314 | 75 | $32.79 | $10K |
| 99291 Critical Care E&M | Facility | 261 | 81 | $175.93 | $46K |
| 90966 ESRD Related Services (not dialysis) | Office | 242 | 43 | $248.69 | $60K |
| 99442 Telephone Services | Office | 201 | 170 | $62.28 | $13K |
| 99203 Office E&M - New | Office | 179 | 179 | $91.27 | $16K |
| 99222 Hospital E&M - Initial | Facility | 128 | 104 | $108.46 | $14K |
| 99231 Hospital E&M - Subsequent | Facility | 123 | 63 | $41.05 | $5,049 |
By year: 2022 $820K for 6,673 services; 2023 $879K for 7,565 services; 2024 $975K for 9,722 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tom Yang prescribed most often to Medicare patients was Losartan Potassium, with 713 prescriptions and refills. In total Tom Yang wrote 5,682 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 713 | 1,618 | 258 | $5,972 |
| Farxiga Dapagliflozin Propanediol | 477 | 684 | 147 | $369K |
| Prosol Parenteral Amino Acid 20% No.1 | 323 | 323 | 13 | $61K |
| Amlodipine Besylate Generic | 242 | 586 | 92 | $1,392 |
| Velphoro Sucroferric Oxyhydroxide | 195 | 199 | 56 | $434K |
| Potassium Chloride Generic | 193 | 427 | 65 | $3,352 |
| Furosemide Generic | 189 | 412 | 74 | $770 |
| Lokelma Sodium Zirconium Cyclosilicate | 174 | 203 | 50 | $123K |
| Sevelamer Carbonate Generic | 158 | 274 | 55 | $24K |
| Tamsulosin Hcl Generic | 142 | 309 | 46 | $1,672 |
| Carvedilol Generic | 130 | 317 | 49 | $800 |
| Hydrochlorothiazide Generic | 113 | 227 | 43 | $500 |
| Nifedipine Er Nifedipine | 112 | 209 | 31 | $4,008 |
| Allopurinol Generic | 98 | 224 | 32 | $818 |
| Atorvastatin Calcium Generic | 94 | 214 | 35 | $472 |
Brand drugs: 1,856 claims; generic drugs: 3,814 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tom Yang $3,478 ($3,478 in general payments such as food, travel and fees) from 13 companies. The largest payer was Ardelyx, Inc. with $696.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 24 | $696 |
| Fresenius USA Marketing, Inc. | 42 | $649 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $319 |
| Amgen Inc. AMGN | 24 | $305 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $302 |
| Calliditas Therapeutics US Inc. | 16 | $291 |
| Akebia Therapeutics Inc AKBA | 9 | $265 |
| Novo Nordisk Inc NVO | 7 | $204 |
| Lilly USA, LLC LLY | 10 | $199 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.